This approval is based on final data from the PRIMA trial, where the MyChoice CDx Test determined homologous recombination deficiency (HRD) status and was used to stratify advanced ovarian cancer ...

Myriad Genetics received approval for a diagnostic test aimed at identifying advanced ovarian cancer patients eligible for treatment with Zejula from the Food and Drug Administration. The diagnostic ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It's the latest example of medical tests that contribute to health ...

Ovarian cancer is treatable is detected early, but 70% of cases aren’t diagnosed until it’s too late. A promising blood test may change that. Each year, about 20,000 women are diagnosed with ovarian ...

Participants will be given a pathology request form and can have the blood test done at a convenient collection centre or at ...

A potential world-changing test developed in Queensland is set to be trialled among 1500 women in the hopes it can be come a ...

As an eager tester of new therapies to reduce her biological age, or how fast she is aging internally, Barnes-Lentz thrives on collecting more data about her health. It’s especially important for her ...